S-100B and FDG-PET/CT in Therapy Response Assessment of Melanoma Patients

Publisher： Karger

E-ISSN： 1421-9832|215|3|192-201

ISSN： 1018-8665

Source： Dermatology, Vol.215, Iss.3, 2007-09, pp. : 192-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute Toxoplasmosis Mimicking Melanoma Metastases: Review of Conditions Causing False-Positive Results on 18F-FDG PET/CT

By  

Dermatology, Vol. 225, Iss. 4, 2013-02 ,pp. : 349-353

Karger

Access to resources Recommend Favorite

Utility of FDG-PET for Staging in a Case of Mycosis Fungoides

By  

Dermatology, Vol. 214, Iss. 2, 2007-03 ,pp. : 185-187

Karger

Access to resources Recommend Favorite

Melanoma Promotion after Photodynamic Therapy of a Suspected Bowen’s Disease Lesion

By  

Dermatology, Vol. 219, Iss. 3, 2009-09 ,pp. : 279-281

Karger

Access to resources Recommend Favorite

Baseline Staging of Melanoma with Unknown Primary Site: The Value of Serum S100 Protein and Positron Emission Tomography

By  

Dermatology, Vol. 217, Iss. 4, 2008-09 ,pp. : 351-355

Karger

Access to resources Recommend Favorite

Detection of Melanoma Relapse: First Comparative Analysis on Imaging Techniques versus S100 Protein

By  

Dermatology, Vol. 213, Iss. 3, 2006-10 ,pp. : 187-191

Karger

Access to resources Recommend Favorite